Title:
阻害剤造影剤
Document Type and Number:
Japanese Patent JP5043438
Kind Code:
B2
Abstract:
The present invention discloses that imaging agents which comprise a specific type of matrix metalloproteinase inhibitors (MMPi's) of the sulphonamide hydroxamate class labelled with an imaging moiety, are useful diagnostic imaging agents for in vivo imaging and diagnosis of the mammalian body.
Inventors:
Cuthbertson, Alan
Solbakken, Magne
Bugato, Emma
Solbakken, Magne
Bugato, Emma
Application Number:
JP2006538954A
Publication Date:
October 10, 2012
Filing Date:
November 12, 2004
Export Citation:
Assignee:
GE HEALTHCARE LIMITED
International Classes:
A61K51/00; A61K31/18; A61K47/48; A61K49/00; A61K49/04; A61K49/06; A61K51/04; A61K51/08
Domestic Patent References:
| JP2003522807A | ||||
| JP2001097854A | ||||
| JP11263735A | ||||
| JP11322705A | ||||
| JP2001512713A |
Foreign References:
| US20020037916 | ||||
| EP0895988A1 |
Other References:
Zheng QH et al.,Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.,Nucl Med Biol. ,2002年10月,29巻7号,pp.761-770
Attorney, Agent or Firm:
Arakawa Satoshi
Hirokazu Ogura
Toshihisa Kurokawa
Hirokazu Ogura
Toshihisa Kurokawa